Title: A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors.
Journal: Investigational new drugs 20120201
Title: The microtubule-active antitumor compound TTI-237 has both paclitaxel-like and vincristine-like properties.
Journal: Cancer chemotherapy and pharmacology 20090901
Title: Cevipabulin (TTI-237): preclinical and clinical results for a novel antimicrotubule agent.
Journal: Methods and findings in experimental and clinical pharmacology 20090901
Title: TTI-237: a novel microtubule-active compound with in vivo antitumor activity.
Journal: Cancer research 20080401
Title: 2-cyanoaminopyrimidines as a class of antitumor agents that promote tubulin polymerization.
Journal: Bioorganic & medicinal chemistry letters 20070601